PARP1 and chronic obstructive pulmonary disease: Predictive analysis of drug-disease targets also unveiled other related genes and molecular pathways involved in COPD regulation and treatment, such as CXCR4, PDGFRB, and PARP1 genes, along with cellular chemokines, tyrosine kinase receptors, and other molecular signaling pathways.